EPA:VIV • FR0000127771
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIVENDI SE (VIV.PA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-07-31 | UBS | Initiate | |
| 2021-03-08 | Credit Suisse | Initiate | Buy |
| 2021-03-04 | Barclays | Initiate | Neutral |
| 2021-02-09 | Credit Suisse | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.595B 10.07% | 312M -96.75% | 297M -4.81% | 309.49M 4.21% | 314.18M 1.52% | 320.29M 1.94% | |
| EBITDA YoY % growth | 1.173B -12.33% | 493M -57.97% | N/A 293.31% | -48.176M -102.48% | -8.766M 81.80% | 9.913M 213.09% | |
| EBIT YoY % growth | 576M 8.88% | -146M -125.35% | -232M -58.90% | -66.781M 71.21% | 6.804M 110.19% | 26.36M 287.42% | |
| Operating Margin | 6.00% | -46.79% | -78.11% | -21.58% | 2.17% | 8.23% | |
| EPS YoY % growth | N/A -29.23% | N/A 75.40% | N/A -81.75% | 0.09 -27.50% | 0.11 26.34% | 0.12 15.17% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
14 analysts have analysed VIV.PA and the average price target is 3.07 EUR. This implies a price increase of 52.13% is expected in the next year compared to the current price of 2.021.
VIVENDI SE (VIV.PA) will report earnings on 2026-03-11, after the market close.
The number of analysts covering VIVENDI SE (VIV.PA) is 14.